HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CIR Panel Prioritizes Paraben Review To Signal EU Before It's 'Too Late'

This article was originally published in The Rose Sheet

Executive Summary

At their March 31-April 1 meeting, CIR's experts opted to tentatively prioritize sodium methylparaben for review in 2017, which could allow them to make a statement on paraben safety in general as regulatory movement in the EU continues to put the ingredients' use in jeopardy.

You may also be interested in...

EU’s Addition Of Butylparaben To SVHC List Won’t Impact Cosmetics Use … Or Will It?

Cosmetic uses of substances of very high concern are excluded from authorization requirements under EU REACH when the substance was listed strictly for endocrine-disrupting concerns. However, cosmetic product manufacturers may find the preservative unavailable from suppliers should butylparaben eventually make the European Chemicals Agency’s Authorization List.

Cosmetic Preservatives Crisis Creeping Into CIR Program

If concerns about cosmetic preservatives are unfounded from a scientific standpoint, then the Cosmetic Ingredient Review Expert Panel should be in a position to set the record straight. However, data gaps have the group considering “insufficient data” findings in pending reviews of parabens and polyaminopropyl biguanide.

CIR Panel's Parabens Review Leaning Toward Safe, But 'Insufficient Data' For Now

Cosmetic Ingredient Review’s independent experts will continue to mull new safety information for parabens, as well as input from a P&G expert, but the panel is inclined to determine the preservatives safe as used in an assessment that could differ “significantly” from European conclusions. 

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts